Panel: Aprotinin should remain on market
602837
A drug used to prevent excessive bleeding during bypass surgery should remain on the market despite being linked to increased risk of death and other serious side effects, federal advisers recommended Wednesday.
522221
Altus Pharmaceuticals still testing drug after Genentech leaves development partnership.
22400
The government said yesterday a controversial abortion pill is safe enough to remain on the market, despite a third death and a grieving father&#39;s plea.
494299
Sanofi-Aventis expects to get a decision from U.S. regulators by April 26 on whether it may sell anti-obesity pill and potential blockbuster Acomplia in the world's largest drug market, following a six-month review.
330315
(230 sec.) How the company can offset the loss of heart drug Torcetrapib.
455531
A panel of experts reaches mixed conclusions on the safety and effectiveness of drug-coated stents.
753455
Pfizer to investors: Don't stop believing.
459566
LONDON/NEW YORK  - A court ruling upholding the patent on blockbuster blood-thinning drug Plavix has reignited talk France's Sanofi-Aventis  will bid for its smaller U.S. partner Bristol-Myers Squibb Co. .
635918
No. 1 drugmaker to end marketing push after study points to higher risk of heart attack, stroke. NEW YORK (CNN) - Under pressure from regulators, Pfizer has agreed to limit advertising of Celebrex after a
452827
The federal Food and Drug Administration&#39;s ability to protect the American public is in question in the wake of the problems with this year&#39;s flu vaccine shortage and claims that it is allowing unsafe drugs to remain on the market.
124942
U.S. regulatory reviewers on Wednesday said it was unclear if Procter & Gamble Co.'s  testosterone patch for boosting sexual desire in women produces meaningful benefit, or is safe over the long term.
662712
GAITHERSBURG, Maryland  - A U.S. advisory panel on Friday was divided over whether current data warrant changes to drug-coated heart stent labels for their use in patients with more medical complications unapproved for the device.
102866
A study suggesting arthritis drug Bextra doubles patients&#39; heart attack and stroke risks drew a sharp rebuttal Wednesday from the drug&#39;s maker, Pfizer (PFE), as its stock price dipped.
722145
Will Pfizer be able to offset the looming loss of Lipitor?
15055
AstraZeneca Plc (AZN) on Friday said US regulators did not approve its anti-clotting drug Exanta. The US Food and Drug Administration followed the advice of an advisory panel, which last
550684
Sanofi-Aventis SA cut its 2006 earnings forecast Friday, warning that generic drug maker Apotex Corp. may have flooded the U.S. market with cheaper copies of the French company's blockbuster blood-thinning pill, Plavix.
471279
The Thursday night rejection of Proctor &amp; Gamble&#39;s (PG:NYSE - news - research) female testosterone sex-drive patch Intrinsa by a Food and Drug Administration advisory panel will almost certainly delay efforts by BioSante to develop its own product, a